ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

The predictive value of pulmonary infarction in patients with acute pulmonary embolism on persistent symptoms and adverse events

F. Kaptein1, L. Kroft2, L. van Dam3, J. Stöger1, M. Ninaber1, M. Huisman4, F. Klok5

1Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 2Department of Radiology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 3Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 4Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Zuid-Holland, Netherlands, 5Leiden University Medical Center, Leiden, the Netherlands, Leiden, Zuid-Holland, Netherlands

Abstract Number: PB1329

Meeting: ISTH 2022 Congress

Theme: Venous Thromboembolism » VTE Epidemiology

Background: Pulmonary infarction (PI) is relatively common in acute pulmonary embolism (PE) with a reported incidence of nearly 30%. The impact on mortality and short-term outcomes seems limited, but the effect on persistent symptoms and functional impairment is largely unknown.

Aims: To evaluate the predictive value of suspected pulmonary infarction at acute PE diagnosis on long-term clinical outcomes.

Methods: We studied an existing cohort of 99 patients with computed tomography pulmonary angiography (CTPA) confirmed acute PE in whom 3-month follow-up data were available. The CTPAs were re-evaluated by an expert thoracic radiologist, who was blinded for clinical outcomes, for signs of PI (i.e. consistent with a peripheral wedge-shaped consolidation in a region of pulmonary embolism, with decreased contrast enhancement; Figure). We investigated the association between signs of PI at PE diagnosis and clinical symptoms at initial presentation, adverse events (recurrent venous thromboembolism, PE-related readmission and mortality) and self-reported persistent symptoms (dyspnea, pain and post-PE functional impairment, the latter defined as ‘new/progressive dyspnea, exercise intolerance and/or diminished functional status following adequately treated PE, without an apparent alternative explanation’) at 3-month follow-up using univariate Cox regression analysis.

Results: At PE diagnosis, 57 patients (58%) had suspected PI, comprising a median of 1% (IQR 1-3) of the total lung parenchyma. Patients with suspected PI presented more often with hemoptysis and pleural pain, and with more proximal PE on CTPA than patients without suspected PI (Table). There was no association with adverse events, persistent dyspnea or pain at 3-month follow-up, but signs of PI predicted more functional impairment (OR 3.0, 95%CI 1.0-9.1).

Conclusion(s): Patients with signs of PI had a different clinical presentation at acute PE diagnosis than patients without those signs, but no association with adverse events was found. Additionally, signs of PI predicted post-PE functional impairment.

Figure

Pulmonary infarction on CT pulmonary angiography

Table

Symptoms and outcomes in patients with and without suspected pulmonary infarction

To cite this abstract in AMA style:

Kaptein F, Kroft L, van Dam L, Stöger J, Ninaber M, Huisman M, Klok F. The predictive value of pulmonary infarction in patients with acute pulmonary embolism on persistent symptoms and adverse events [abstract]. https://abstracts.isth.org/abstract/the-predictive-value-of-pulmonary-infarction-in-patients-with-acute-pulmonary-embolism-on-persistent-symptoms-and-adverse-events/. Accessed September 21, 2023.

« Back to ISTH 2022 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/the-predictive-value-of-pulmonary-infarction-in-patients-with-acute-pulmonary-embolism-on-persistent-symptoms-and-adverse-events/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley